# Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

> **NCT00100633** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (—)

## Conditions studied

- HIV Infections
- Hepatitis B

## Interventions

- **DRUG:** CpG7909 oligodeoxynucleotides (ODN)
- **BIOLOGICAL:** Hepatitis B virus vaccine

## Key facts

- **NCT ID:** NCT00100633
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-02
- **Final completion:** 2007-10
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100633, "Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00100633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*